Abdominal Cancer Completed Phase 3 Trials for Bupivacaine (DB00297)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0036156 (Abdominal Cancer) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02927379 | Effect of Wound Infiltration by Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical Stress | Health Services Research |